CNJ-H01

N/A

Report date: 2023/02/04 20:21:31

Base Information

Drug NameCNJ-H01

Drug Alias NameCNJ-H01

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsHepatitis C

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesCangene Corp

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCangene Corp

Active IndicationsN/A

Inactive IndicationsHepatitis C

ATC CodeN/A